senstivity as agent. Tablet 108 250 mg GH CHC PHC OPD Final Tablet 59 selection 109 500 mg GH CHC PHC OPD depends on indication 200 mg/ 110 for use Injection IV GH CHC PHC IPD 100 ml 500 mg + 60 111 Tablet GH CHC PHC OPD 600 mg +Tinidazole Capsule 61 112 Doxycycline 100 mg GH CHC PHC OPD 113 Tablet 500 mg GH OPD Oral 62 125 mg/5 Base 114 suspension GH OPD ml,30ml powder Injection 40 mg/ ml, 63 115 GH CHC PHC IPD Gentamycin (sulphate) 2 ml vial Sub 116 Tablet 200 mg GH CHC PHC OPD centre Sub 117 Tablet 400 mg GH CHC PHC OPD centre 64 500 mg/ 118 Injection GH CHC PHC IPD 100ml 200 mg/50 119 Suspension GH CHC PHC OPD ml 100 mg +20 Sub 120 Tablet GH CHC PHC OPD + mg centre 65 800 mg + 121 Tablet GH CHC PHC OPD 160 mg 6.3 Antifungal medicines Sub 122 Pessaries 200 mg GH CHC PHC OPD 66 centre 123 Cream 2%,30 gm GH CHC PHC OPD
senstivity as agent. 59 108 Final selection depends on indication for use Tablet 250 mg GH CHC PHC OPD 109 Tablet 500 mg GH CHC PHC OPD 110 Injection IV 200 mg/ 100 ml GH CHC PHC IPD 60 111 +Tinidazole Tablet 500 mg + 600 mg GH CHC PHC OPD 61 112 Doxycycline Capsule 100 mg GH CHC PHC OPD 62 113 Base Tablet 500 mg GH OPD 114 Oral suspension powder 125 mg/5 ml,30ml GH OPD 63 115 Gentamycin Injection (sulphate) 40 mg/ ml, 2 ml vial GH CHC PHC IPD 64 116 Tablet 200 mg GH CHC PHC Sub centre OPD 117 Tablet 400 mg GH CHC PHC Sub centre OPD 118 Injection 500 mg/ 100ml GH CHC PHC IPD 119 Suspension 200 mg/50 ml GH CHC PHC OPD 65 120 + Tablet 100 mg +20 mg GH CHC PHC Sub centre OPD 121 Tablet 800 mg + 160 mg GH CHC PHC OPD 6.3 Antifungal medicines 66 122 Pessaries 200 mg GH CHC PHC Sub centre OPD 123 Cream 2%,30 gm GH CHC PHC OPD